SEND Example.In vivo Macroscopic Evaluation of Injection Site (MA)

These are example records of a macroscopic evaluation of injection sites (as indicated in FOCID).

ma.xpt

Row	STUDYID	DOMAIN	USUBJID	FOCID	MASEQ	MASPID	MASTESTCD	MATEST	MAORRES	MASTRESC	MASPEC	MALAT	MADIR	MASEV
1	12345	MA	12345001	Injection site 1	1		GROSPATH	Gross Pathological Examination	Fur thin cover	Focal hair loss	SKIN	LEFT	DORSOCRANIAL
2	12345	MA	12345001	Injection site 2	2		GROSPATH	Gross Pathological Examination	Unremarkable	UNREMARKABLE	SKIN	RIGHT	DORSOCRANIAL
3	12345	MA	12345001	Injection site 3	3		GROSPATH	Gross Pathological Examination	Focal hemorrhage	Hemorrhage	SKIN	LEFT	DORSOCAUDAL
4	12345	MA	12345001	Injection site 4	4	MASS 1	GROSPATH	Gross Pathological Examination	Mass, approximately 8 mm long, 4 mm thick, pale firm well defined	Mass	SKIN	RIGHT	DORSOCAUDAL
5	12345	MA	12345002	Injection site 1	1		GROSPATH	Gross Pathological Examination	Unremarkable	UNREMARKABLE	SKIN	LEFT	DORSOCRANIAL
6	12345	MA	12345002	Injection site 2	2		GROSPATH	Gross Pathological Examination	Discoloration; subcutaneous; red; slight	Discoloration	SKIN	RIGHT	DORSOCRANIAL	MILD
7	12345	MA	12345002	Injection site 3	3		GROSPATH	Gross Pathological Examination	Unremarkable	UNREMARKABLE	SKIN	LEFT	DORSOCAUDAL
8	12345	MA	12345002	Injection site 4	4		GROSPATH	Gross Pathological Examination	Mucosal hemorrhage (about 2x2 cm), moderate	Hemorrhage	SKIN	RIGHT	DORSOCAUDAL	MODERATE

$warningHtml

Note that the concept of "MASS 1" (in CLSPID) is different from "Injection site 1" (in FOCID), in that information in the FOCID variable is known prior to the examination, but the mass ID/applicant identifier is assigned as part of the examination. FOCID thereby qualifies the test, whereas CLSPID qualifies the result.

cl.xpt

Row	STUDYID	DOMAIN	USUBJID	FOCID	CLSEQ	CLSPID	CLTESTCD	CLTEST	CLCAT	CLORRES	CLSTRESC	CLLOC	CLSEV	CLDTC	CLDY	CLNOMDY
1	12345	CL	12345001	Injection site 1	1		SKINEX	Skin Examination	CLINICAL SIGNS	Fur, Thin Cover; Left Scapula	Fur, Thin Cover	Left Scapula		2004-07-19	42	42
2	12345	CL	12345001	Injection site 2	2		SKINEX	Skin Examination	CLINICAL SIGNS	No Abnormal Findings, Right Scapula	Unremarkable	Right Scapula		2004-07-19	42	42
3	12345	CL	12345001	Injection site 3	3		SKINEX	Skin Examination	CLINICAL SIGNS	No Abnormal Findings, Left Medial Back	Unremarkable	Left Medial Back		2004-07-19	42	42
4	12345	CL	12345001	Injection site 4	4	MASS 1	SKINEX	Skin Examination	CLINICAL SIGNS	Moderate Swelling, Right Medial Back	Swelling	Right Medial Back	MODERATE	2004-07-19	42	42
5	12345	CL	12345002	Injection site 1	1		SKINEX	Skin Examination	CLINICAL SIGNS	No Abnormal Findings, Left Scapula	Unremarkable	Left Scapula		2004-07-19	42	42
6	12345	CL	12345002	Injection site 2	2		SKINEX	Skin Examination	CLINICAL SIGNS	Slight Reddening, Right Scapula	Reddening	Right Scapula	MILD	2004-07-19	42	42
7	12345	CL	12345002	Injection site 3	3		SKINEX	Skin Examination	CLINICAL SIGNS	Abrasion, Left Medial Back	Abrasion	Left Medial Back		2004-07-19	42	42
8	12345	CL	12345002	Injection site 4	4		SKINEX	Skin Examination	CLINICAL SIGNS	Moderate Reddening, Right Medial Back	Reddening	Right Medial Back	MODERATE	2004-07-19	42	42

$warningHtml

Page tree

SEND Example.In vivo Macroscopic Evaluation of Injection Site (MA)